The pharmacokinetics of oxcarbazepine and its active metabolite 10‐hydroxy‐carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid
Authors:
- 1 October 1993
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 36 (4) , 366-368
Abstract
The kinetics of oxcarbazepine (OXC) and its active metabolite 10‐hydroxy‐carbazepine (10‐OH‐CZ) after a single oral OXC dose (600 mg) were compared in healthy control subjects and in epileptic patients treated with phenobarbitone or sodium valproate (n = 8 in each group). In all groups, serum 10‐OH‐CZ concentrations were much higher than those of the parent drug. In patients on valproate, the kinetics of OXC and 10‐OH‐CZ did not differ significantly from those observed in controls. In patients on phenobarbitone, AUC values of both OXC and 10‐OH‐CZ were lower than in controls (2.9 ± 0.4 vs 5.1 ± 0.7 μg ml−1 h and 89 ± 7 vs 119 ± 10 μg ml−1 h respectively, means ± s.e. mean, P < 0.05), whereas 10‐OH‐CZ half‐lives were only marginally shorter (17 ± 1 h vs 20 ± 2 h, NS). These data indicate that the biotransformation of OXC and 10‐OH‐CZ may be accelerated by concomitant treatment with phenobarbitone but that the magnitude of this effect is unlikely to be of great clinical significance.Keywords
This publication has 9 references indexed in Scilit:
- OxcarbazepineDrugs, 1992
- Drug Interactions in EpilepsyEpilepsia, 1992
- Differential effects of valproic acid and enzyme‐inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients.British Journal of Clinical Pharmacology, 1991
- Simple and rapid micro-analytical high-performance liquid chromatographic technique for the assay of oxcarbazepine and its primary active metabolite 10-hydroxycarbazepineJournal of Chromatography B: Biomedical Sciences and Applications, 1990
- Interaction of Carbamazepine‐10,11‐Epoxide, an Active Metabolite of Carbamazepine, with Valproate: A Pharmacokinetic StudyEpilepsia, 1990
- Oxcarbazepine disposition: Preliminary observations in patientsBiopharmaceutics & Drug Disposition, 1990
- Clinically Relevant Anti-Epileptic Drug InteractionsJournal of International Medical Research, 1990
- First dose and steady-state pharmacokinetics of oxcarbazepine and its 10-hydroxy metaboliteEuropean Journal of Clinical Pharmacology, 1989
- Acute Effects of Lamotrigine (BW430C) in Persons With EpilepsyEpilepsia, 1986